Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon
George F. Araj, Joseph M. Matar, Chaza K. Al Ghor, Ghena M. Sobh, Clara R. Dagher · 2026
Read Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon by George F. Araj, Joseph M. Matar, Chaza K. Al Ghor, Ghena M. Sobh, Clara R. Dagher (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13645548.txt.
Description
George F. Araj and four colleagues present a laboratory study from Lebanon on gut bacteria that resist carbapenem drugs, a last-line group of antibiotics. The team examined 100 Escherichia coli and 40 Klebsiella pneumoniae samples taken from patients. They identified which resistance enzymes the bacteria carried. They also tested how well routine and newer drugs worked against them.
Only two enzyme types appeared, called NDM and OXA-48, and NDM was the more common of the two. Newer drugs worked better on the E. coli samples than on the Klebsiella ones, and better on OXA-48 strains than on NDM strains. Resistance to drugs not yet even used in Lebanon was already high. The authors urge tighter control of antibiotic use and stronger infection control in hospitals.
Catalog record
| CREATOR | George F. Araj, Joseph M. Matar, Chaza K. Al Ghor, Ghena M. Sobh, Clara R. Dagher |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |